Verifying the early diagnostic method of adenovirus-induced hemorrhagic cystitis after allogeneic hematopoietic stem cells transplantation

Verifying the early diagnostic method of adenovirus-induced hemorrhagic cystitis after allogeneic hematopoietic stem cells transplantation - Early diagnosis of adenovirus-induced hemorrhagic cystitis after allo-HSCT

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000021015

Enrollment

Registered

2016-02-14

Start date

2016-02-15

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

adenovirus-induced hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation

Interventions

Urinary adenoviral DNA is quantified in accordance with the schedule below. 1. Before the start of conditioning chemotherapy 2. Every two weeks after allogeneic hematopoietic stem cell transplantati

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patients who have a plan to undergo allogeneic hematopoietic stem cell transplantation 2. Patients who are going to be hospitalized for at least four weeks 3. Patients who agree in writing

Exclusion criteria

Exclusion criteria: 1. Patients whom hemorrhagic cystitis has already developed 2. Patients who are recognized as inadaptable for this trial

Design outcomes

Primary

Measure	Time frame
The efficacy of quantifying urinary adenoviral DNA for diagnosis of adenovirus-induced hemorrhagic cystitis	—

Countries

Japan

Contacts

Public ContactYukio Kondo

Kanazawa University Hospital Department of Hematology

y-kondo@staff.kanazawa-u.ac.jp076-234-2275

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026